A client is admitted to the hospital with a diagnosis of R/O appendicitis. Which abbreviation would describe the location of a client's appendix?

Choice A rationale: Intravenous administration results in the most predictable onset and complete bioavailability to the client, as the medication goes directly into the bloodstream.

Choice B rationale: Oral administration is subject to factors such as absorption in the gastrointestinal tract, which can affect predictability and bioavailability.

Choice C rationale: Subcutaneous administration can be affected by factors like absorption rates and tissue characteristics, leading to variations in onset and bioavailability.

Choice D rationale: Transdermal administration has a slower onset and may be influenced by factors such as skin integrity and blood flow.

Choice A rationale: Compensating for an ongoing problem affecting other fluid or electrolytes is a common rationale for IV therapy.

Choice B rationale: Increasing urine specific gravity to 1.045 is not a typical goal for IV therapy. IV therapy would decrease the urine specific gravity by diluting the urine with fluids.

Choice C rationale: Moving fluid into an area that is physiologically unavailable is not a primary goal of IV therapy. Physiologically unavailable areas are those that are separated from the rest of the body by a membrane or barrier, such as the cerebrospinal fluid, the intraocular fluid, or the pleural fluid. IV therapy does not cross these barriers and only affects the intravascular and interstitial spaces.

Choice D rationale: Correcting imbalance in fluid and electrolytes is a primary goal of IV therapy.

Choice E rationale: Expanding intravascular volume is a common goal of IV therapy, especially in cases of dehydration or hypovolemia.